US Stem Cell Inc (USRM)

[Archery Class]

Yes, and my hope is that they have a backup plan to deal with any issues in obtaining RMAT designation.

Their previous endeavor had them back and forth with the FDA until placing RMAT on the back-burner.

But what happens to the company if the same thing happens after guidelines? They go through some similar song and dance with the FDA only to find the process stalled or not worth pursuing?

I’m hopeful that such a catalyst as RMAT will be taken advantage of here, but I? want to know what else USRM could benefit from as an impending catalyst. The world is primed to openly accept stem cell procedures, surely RMAT isn’t their only avenue for a big leg up.